Bloom HoldCo LLC

2024 Q3 Form 10-Q Financial Statement

#000121390024068986 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.533M
Short-Term Investments
Other Short-Term Assets $500.0K
YoY Change -18.17%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.087M
YoY Change -44.81%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $26.00K
YoY Change -10.34%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.326M
YoY Change -45.77%
TOTAL ASSETS
Total Short-Term Assets $4.087M
Total Long-Term Assets $3.326M
Total Assets $7.413M
YoY Change -45.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $359.0K
YoY Change -23.94%
Accrued Expenses $200.0K
YoY Change 365.12%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $37.57M
YoY Change -13.99%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $37.57M
Total Long-Term Liabilities
Total Liabilities $39.45M
YoY Change -13.96%
SHAREHOLDERS EQUITY
Retained Earnings -$32.00M
YoY Change -0.95%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$32.03M
YoY Change
Total Liabilities & Shareholders Equity $7.413M
YoY Change -45.24%

Cashflow Statement

Concept 2024 Q3 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
53.11
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-201.62
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
usd
CY2023Q3 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
usd
CY2024Q2 blhl Limited Partners Capital Account No Par Value
LimitedPartnersCapitalAccountNoParValue
CY2023Q3 blhl Limited Partners Capital Account No Par Value
LimitedPartnersCapitalAccountNoParValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56556
dei Entity Registrant Name
EntityRegistrantName
Bloom HoldCo LLC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-4706208
dei Entity Address Address Line1
EntityAddressAddressLine1
PMBS 1387
dei Entity Address Address Line2
EntityAddressAddressLine2
1000 Brickell Avenue
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 715
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33131
dei City Area Code
CityAreaCode
(850)
dei Local Phone Number
LocalPhoneNumber
660-7301
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9000 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3533000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5556000 usd
CY2024Q2 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
507000 usd
CY2023Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
611000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
4087000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
6204000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
300000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
300000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3000000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28000 usd
CY2024Q2 us-gaap Assets
Assets
7413000 usd
CY2023Q3 us-gaap Assets
Assets
9532000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
359000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
295000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
216000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
329000 usd
CY2024Q2 blhl Accrued Liability For Member Distributions Current
AccruedLiabilityForMemberDistributionsCurrent
1813000 usd
CY2023Q3 blhl Accrued Liability For Member Distributions Current
AccruedLiabilityForMemberDistributionsCurrent
1813000 usd
CY2024Q2 blhl Token Sale Liabilities
TokenSaleLiabilities
29475000 usd
CY2023Q3 blhl Token Sale Liabilities
TokenSaleLiabilities
32253000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
5314000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4847000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
394000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
343000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
37571000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
39880000 usd
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1875000 usd
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2163000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
39446000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
42043000 usd
CY2024Q2 us-gaap Limited Partners Capital Account Units Authorized
LimitedPartnersCapitalAccountUnitsAuthorized
10000 shares
CY2023Q3 us-gaap Limited Partners Capital Account Units Authorized
LimitedPartnersCapitalAccountUnitsAuthorized
10000 shares
CY2024Q2 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
9000 shares
CY2023Q3 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
9000 shares
CY2024Q2 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
9000 shares
CY2023Q3 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
9000 shares
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32033000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32511000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-32033000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-32511000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7413000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9532000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
885000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2021000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2874000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4128000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 usd
CY2024Q2 us-gaap Crypto Asset Realized Gain Operating
CryptoAssetRealizedGainOperating
4462000 usd
us-gaap Crypto Asset Realized Gain Operating
CryptoAssetRealizedGainOperating
4462000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
-3576000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2023000 usd
us-gaap Operating Expenses
OperatingExpenses
-1586000 usd
us-gaap Operating Expenses
OperatingExpenses
4134000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3576000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2023000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1586000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4134000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
118000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
244000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
780000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
875000 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
126000 usd
us-gaap Other Expenses
OtherExpenses
126000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-118000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-370000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-780000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1001000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3458000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2393000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
806000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5135000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-578000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
328000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1248000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
3434000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1815000 usd
us-gaap Net Income Loss
NetIncomeLoss
478000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3887000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
381.56
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-201.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
53.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-431.89
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-32511000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1507000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-34018000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1449000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-35467000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
3434000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-32033000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-28421000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1383000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-29804000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-689000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-30493000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1815000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-32308000 usd
us-gaap Net Income Loss
NetIncomeLoss
478000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3887000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6000 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-4462000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
328000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1248000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
64000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
328000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-113000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6000 usd
blhl Increase Decreasein Accrued Liability For Member Distributions
IncreaseDecreaseinAccruedLiabilityForMemberDistributions
480000 usd
blhl Increase Decreasein Token Sale Liability
IncreaseDecreaseinTokenSaleLiability
-2778000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
467000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
982000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-565000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-164000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2335000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3483000 usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
4358000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4358000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2023000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3483000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5856000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10535000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3833000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7052000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
277000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
289000 usd
CY2018Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
32300000 usd
CY2022Q3 blhl Penalty Pay
PenaltyPay
300000 usd
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
30900000 usd
blhl Total Possible Penalty
TotalPossiblePenalty
30900000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
32300000 usd
CY2024Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
3800000 usd
CY2024Q2 blhl Claim Value
ClaimValue
3300000 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
500000 usd
CY2024Q2 blhl Payment Not Accepted By The Claimants Financial Institution
PaymentNotAcceptedByTheClaimantsFinancialInstitution
600000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3800000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
300000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, as well as the reported amounts of expenses during the reporting period. The most significant estimates inherent in the preparation of the Company’s unaudited condensed consolidated financial statements include, but are not limited to, estimates of interest payable on the token sale liability, among others. These estimates and assumptions are based on the Company’s historical experience, and on various other factors that management believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. To the extent there are material differences between the estimates and actual results, the Company’s future results of operations will be affected.</p>
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
5300000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4800000 usd
blhl Internal Revenue Service Interest Rate
InternalRevenueServiceInterestRate
0.0468 pure
CY2023 blhl Internal Revenue Service Interest Rate
InternalRevenueServiceInterestRate
0.0411 pure
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 pure
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 pure
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
200000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
300000 usd
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
3300000 usd
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
600000 usd
CY2023Q3 blhl Accrued Liability For Member Distributions Current
AccruedLiabilityForMemberDistributionsCurrent
1800000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
400000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
300000 usd
CY2024Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
3600000 usd
blhl Annual Installments
AnnualInstallments
P8Y
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1900000 usd
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2200000 usd
CY2024Q2 us-gaap Limited Partners Capital Account Units Authorized
LimitedPartnersCapitalAccountUnitsAuthorized
10000 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
609 shares
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
609 shares
blhl Number Of Tokens
NumberOfTokens
1350 pure
CY2024Q2 blhl Token Sale Liability
TokenSaleLiability
4600000 usd
CY2024Q2 blhl Token Sale Liability
TokenSaleLiability
4600000 usd
CY2023Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
611000 usd
CY2022Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
611000 usd
us-gaap Crypto Asset Sale
CryptoAssetSale
104000 usd
CY2024Q2 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
507000 usd
CY2023Q3 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
611000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
6523 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
7872 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Crypto Asset Realized Gain Operating
CryptoAssetRealizedGainOperating
usd
us-gaap Crypto Asset Realized Gain Operating
CryptoAssetRealizedGainOperating
usd
CY2024Q2 us-gaap Other Expenses
OtherExpenses
usd
us-gaap Other Expenses
OtherExpenses
usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
381.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-431.89
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9000 shares
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
blhl Increase Decreasein Accrued Liability For Member Distributions
IncreaseDecreaseinAccruedLiabilityForMemberDistributions
usd
blhl Increase Decreasein Token Sale Liability
IncreaseDecreaseinTokenSaleLiability
usd
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Income Loss
NetIncomeLoss
500000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
shares
CY2023 us-gaap Crypto Asset Sale
CryptoAssetSale
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001975931

Files In Submission

Name View Source Status
0001213900-24-068986-index-headers.html Edgar Link pending
0001213900-24-068986-index.html Edgar Link pending
0001213900-24-068986.txt Edgar Link pending
0001213900-24-068986-xbrl.zip Edgar Link pending
blhl-20240630.xsd Edgar Link pending
ea0209718-10q_bloomhold.htm Edgar Link pending
ea020971801ex31-1_bloom.htm Edgar Link pending
ea020971801ex31-2_bloom.htm Edgar Link pending
ea020971801ex32-1_bloom.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
blhl-20240630_cal.xml Edgar Link unprocessable
blhl-20240630_def.xml Edgar Link unprocessable
blhl-20240630_lab.xml Edgar Link unprocessable
blhl-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0209718-10q_bloomhold_htm.xml Edgar Link completed